BioMarin Pharmaceuticals
BMRN
BMRN
481 hedge funds and large institutions have $15.3B invested in BioMarin Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 174 increasing their positions, 173 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 484 → 481 (-3)
4% less capital invested
Capital invested by funds: $15.9B → $15.3B (-$601M)
37% less call options, than puts
Call options by funds: $106M | Put options by funds: $168M
Holders
481
Holding in Top 10
10
Calls
$106M
Puts
$168M
Top Buyers
| 1 | +$258M | |
| 2 | +$178M | |
| 3 | +$167M | |
| 4 |
YCMGA
York Capital Management Global Advisors
New York
|
+$95.6M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$85.2M |
Top Sellers
| 1 | -$254M | |
| 2 | -$217M | |
| 3 | -$151M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$80.8M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$71.2M |